Navamedic ASA: Invitation to 2022 third quarter presentation

Published: 25.10.2022

Navamedic ASA launches ForlaxGO® – an innovative on-the-go product for the treatment of constipation

Published: 20.10.2022

Navamedic ASA: Q2 and first half 2022 financial results

Published: 12.08.2022

Navamedic ASA: Invitation to 2022 second quarter presentation

Published: 09.08.2022

Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig®

Published: 04.08.2022

Navamedic ASA: Trading Update

Published: 04.07.2022